Albert Puig-Pijoan
Articles
-
Apr 4, 2024 |
nature.com | Fernando Gonzalez-Ortiz |Jose Celso Contador |Geir Bråthen |Przemyslaw R. Kac |Johanna Nilsson |Kathleen Hayden | +5 more
AbstractStaging amyloid-beta (Aβ) pathophysiology according to the intensity of neurodegeneration could identify individuals at risk for cognitive decline in Alzheimer’s disease (AD). In blood, phosphorylated tau (p-tau) associates with Aβ pathophysiology but an AD-type neurodegeneration biomarker has been lacking.
-
Apr 4, 2024 |
AbstractStaging amyloid-beta (Aβ) pathophysiology according to the intensity of neurodegeneration could identify individuals at risk for cognitive decline in Alzheimer’s disease (AD). In blood, phosphorylated tau (p-tau) associates with Aβ pathophysiology but an AD-type neurodegeneration biomarker has been lacking.
-
Mar 15, 2023 |
alz-journals.onlinelibrary.wiley.com | Bruna Bellaver |João Pedro Ferrari-Souza |Douglas T. Leffa |Albert Puig-Pijoan
Get access to the full version of this article. View access options below. Purchase Instant Access Item saved, go to cart 48-Hour online access $10.00 Details View the article/chapter PDF and any associated supplements and figures for a period of 48 hours. Article/Chapter can not be printed. Article/Chapter can not be downloaded. Article/Chapter can not be redistributed.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →